VORTEXA LTD
Company number 09966213 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Risk Rating: MEDIUM
Justification: VORTEXA LTD is an active private company with filings up to date and audited group accounts for the year ended 31 December 2025. The auditors have endorsed the going concern basis, and the company has secured a $50 million debt facility after the year end. However, the reported balance sheet shows negative net assets (approximately £-20.0 million) and negative shareholders funds (approximately £-80.7 million), with total liabilities exceeding total assets. The company is loss-making and appears dependent on continued external financing, while the summary financial data contains internal inconsistencies that require verification against the primary filed accounts.
Key Concerns
-
Negative equity and balance sheet position: Reported net assets of £-20.0 million and shareholders funds of £-80.7 million at 31 December 2025 indicate that accumulated losses exceed invested capital. Total liabilities of approximately £26.1 million exceed total assets of approximately £22.2 million, which is a material solvency indicator on an accounting basis.
-
Recurring losses and cash burn: The group reported an operating loss of $16.6 million and a loss after tax of $18.9 million for 2025. Cash and cash equivalents declined from £17.8 million at 31 January 2024 to £5.3 million at 31 December 2025, indicating significant operating cash consumption.
-
Data integrity and reporting currency: The summary financial history appears internally inconsistent (for example, net assets and shareholders funds do not reconcile with total assets and liabilities, and figures are presented in GBP while the strategic report discusses USD amounts). These discrepancies must be resolved against the audited accounts before reliance.
Positive Indicators
- Regulatory compliance: Accounts and confirmation statement are not overdue; the company is active and not in liquidation, administration, or receivership.
- Revenue growth and margin: Group turnover increased to $16.2 million from $11.7 million (annualised $12.7 million), representing approximately 28% underlying growth, with a gross profit margin of 82%.
- Recent financing: A $15.4 million convertible loan note was completed in July 2025, followed by a $50 million strategic debt facility with Oxford Finance LLC in March 2026, refinancing existing arrangements and providing additional capacity.
- Auditor going concern opinion: The independent auditors concluded that the going concern basis is appropriate and identified no material uncertainties over the next twelve months.
Due Diligence Notes
- Reconcile the difference between reported net assets (£-20.0 million) and shareholders funds (£-80.7 million), and verify total assets and total liabilities against the audited balance sheet, as the summary figures appear not to reconcile.
- Confirm the functional and reporting currency, clarifying why the historical summary is in GBP while the strategic report is denominated in USD.
- Review the terms of the $50 million Oxford Finance facility and the $15.4 million convertible loan note, including covenants, maturity, interest, security, and conversion mechanics.
- Obtain the consolidated cash flow statement to distinguish operating cash burn from financing inflows.
- Examine the group structure, including the four subsidiaries referenced in the accounts, and any cross-guarantees or intra-group liabilities.
- Verify the accounting reference date change from 31 January to 31 December and adjust comparatives accordingly.
- Confirm the PSC register and director details against the latest confirmation statement.